Your browser doesn't support javascript.
loading
TaqTth-hpRNA: a novel compact RNA-targeting tool for specific silencing of pathogenic mRNA.
Xu, Chong; Cao, Jiyanuo; Qiang, Huanran; Liu, Yu; Wu, Jialin; Luo, Qiudan; Wan, Meng; Wang, Yujie; Wang, Peiliang; Cheng, Qian; Zhou, Guohua; Sima, Jian; Guo, Yongjian; Xu, Shu.
Affiliation
  • Xu C; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Cao J; Laboratory of Aging Neuroscience and Neuropharmacology, China Pharmaceutical University, Nanjing, 210009, China.
  • Qiang H; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Liu Y; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Wu J; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Luo Q; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Wan M; Laboratory of Aging Neuroscience and Neuropharmacology, China Pharmaceutical University, Nanjing, 210009, China.
  • Wang Y; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Wang P; Laboratory of Aging Neuroscience and Neuropharmacology, China Pharmaceutical University, Nanjing, 210009, China.
  • Cheng Q; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Zhou G; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Sima J; Laboratory of Aging Neuroscience and Neuropharmacology, China Pharmaceutical University, Nanjing, 210009, China.
  • Guo Y; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
  • Xu S; School of Basic Medical Science and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
Genome Biol ; 25(1): 179, 2024 Jul 07.
Article in En | MEDLINE | ID: mdl-38972974
ABSTRACT
Pathogenic allele silencing is a promising treatment for genetic hereditary diseases. Here, we develop an RNA-cleaving tool, TaqTth-hpRNA, consisting of a small, chimeric TaqTth, and a hairpin RNA guiding probe. With a minimal flanking sequence-motif requirement, in vitro and in vivo studies show TaqTth-hpRNA cleaves RNA efficiently and specifically. In an Alzheimer's disease model, we demonstrate silencing of mutant APPswe mRNA without altering the wild-type APP mRNA. Notably, due to the compact size of TaqTth, we are able to combine with APOE2 overexpression in a single AAV vector, which results in stronger inhibition of pathologies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Gene Silencing / Alzheimer Disease Limits: Animals / Humans Language: En Journal: Genome Biol / Genome biol / Genome biology (Online) Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Gene Silencing / Alzheimer Disease Limits: Animals / Humans Language: En Journal: Genome Biol / Genome biol / Genome biology (Online) Year: 2024 Document type: Article